Milestone Pharmaceuticals (MIST) Payables (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Payables of $10.0 million for Q1 2026, up 77.56% on a QoQ basis from $5.6 million in Q4 2025, and up 320.43% year-over-year from $2.4 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Payables (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Payables history runs 9 years deep, the most recent figure standing at $10.0 million for Q1 2026.
- Quarterly Payables rose 320.43% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (up 320.43% YoY) and the FY2025 annual result came in at $5.6 million, down 25.28% from the prior year.
- Payables was $10.0 million for Q1 2026 at Milestone Pharmaceuticals, up from $5.6 million in the prior quarter.
- Across five years, Payables topped out at $10.0 million in Q3 2025 and bottomed at $1.7 million in Q1 2024.
- A 5-year average of $5.6 million and a median of $5.6 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables plunged 76.73% — and 2026, when it soared 320.43%.
- Milestone Pharmaceuticals' Payables stood at $5.6 million in 2022, then grew by 18.36% to $6.7 million in 2023, then grew by 13.1% to $7.6 million in 2024, then fell by 25.28% to $5.6 million in 2025, then surged by 77.56% to $10.0 million in 2026.
- Business Quant data shows MIST's Payables at $10.0 million in Q1 2026, $5.6 million in Q4 2025, and $10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 8.77 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 6.68 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 5.64 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 5.07 Mn |